The use of vasoconstrictor agents like vasopressin during laparoscopic myomectomy reduces blood loss during surgery and reduces operative time. However, certain side effects related to the cardiovascular system have also been reported with its use. These side effects could possibly be due to inadvertent intravascular injection of the drug. The author aims to describe a new design of an injection needle, Pisat's Visual Vasopressor Injection Needle (VVIN) that can be used during laparoscopic myomectomy to reduce the likelihood of an inadvertent intravascular injection of a vasoconstrictor solution.